Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Rosenthal

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Nature Biotechnology|August 30, 2016
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodesAmalie Kai Bentzen, Andrea Marion Marquard, Rikke Lyngaa, et al.
Trials|June 3, 2014
Evaluating the optimal timing of surgical antimicrobial prophylaxis: study protocol for a randomized controlled trialEdin Mujagic, Tibor Zwimpfer, Walter R Marti, et al.
The Lancet. Oncology|July 12, 2017
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysisSamra Turajlic, Kevin Litchfield, Hang Xu, et al.
Nature Medicine|May 29, 2020
Geospatial immune variability illuminates differential evolution of lung adenocarcinomaKhalid AbdulJabbar, Shan E Ahmed Raza, Rachel Rosenthal, et al.
Nature Genetics|October 2, 2024
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolutionClare Puttick, Thomas P Jones, Michelle M Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2021
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune EvasionFabio Conforti, Laura Pala, Eleonora Pagan, et al.
The Lancet. Infectious Diseases|April 8, 2017
Timing of surgical antimicrobial prophylaxis: a phase 3 randomised controlled trialWalter P Weber, Edin Mujagic, Marcel Zwahlen, et al.
Nature|March 22, 2019
Neoantigen-directed immune escape in lung cancer evolutionRachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, et al.
Cell|January 28, 2021
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibitionKevin Litchfield, James L Reading, Clare Puttick, et al.
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Nature Biotechnology|August 30, 2016
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodesAmalie Kai Bentzen, Andrea Marion Marquard, Rikke Lyngaa, et al.
Trials|June 3, 2014
Evaluating the optimal timing of surgical antimicrobial prophylaxis: study protocol for a randomized controlled trialEdin Mujagic, Tibor Zwimpfer, Walter R Marti, et al.
The Lancet. Oncology|July 12, 2017
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysisSamra Turajlic, Kevin Litchfield, Hang Xu, et al.
Nature Medicine|May 29, 2020
Geospatial immune variability illuminates differential evolution of lung adenocarcinomaKhalid AbdulJabbar, Shan E Ahmed Raza, Rachel Rosenthal, et al.
Nature Genetics|October 2, 2024
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolutionClare Puttick, Thomas P Jones, Michelle M Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2021
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune EvasionFabio Conforti, Laura Pala, Eleonora Pagan, et al.
The Lancet. Infectious Diseases|April 8, 2017
Timing of surgical antimicrobial prophylaxis: a phase 3 randomised controlled trialWalter P Weber, Edin Mujagic, Marcel Zwahlen, et al.
Nature|March 22, 2019
Neoantigen-directed immune escape in lung cancer evolutionRachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, et al.
Cell|January 28, 2021
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibitionKevin Litchfield, James L Reading, Clare Puttick, et al.
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Pageof 12